How to know the good from the bad? The differen
Post# of 1040
Posted On: 03/13/2015 11:36:40 AM
How to know the good from the bad?
The differences that really standout between all these CBD companies flooding the market is quickly distinguished by who is supporting and endorsing them. Inergetics has the BEST of the BEST, who actually have a long background working and studying within the medical and scientific marijuana industry for many years. NRTI didn't just go out and pay someone to use their name to promote their company, they brought these experts in to also assist in making their CBD products, backed up with their research and clinical evidence. Inergetics has not only taken the right approach, but they have taken the approach physicians and clinicians will trust. This will make all the difference when this is launched throughout the US. The FDA is already taking steps to crack down on the masses of hustlers and unreliable companies in this space. Inergetics approach will be setting the new standard that the FDA will appreciate and look to adopt, to make the medical mj industry much safer for the public. In the end, only a few will be around, but some like NRTI, will not only survive, but will also lead the category! Cheers!
Inergetics SUPPORT & ENDORSEMENTS:
They brought in the most notable authorities in the medical marijuana industry to help create and endorse their one of a kind CBD products that they have also provided the scientific research and medical evidence to support its efficacy and safety. This impressive Scientific/Medical Advisory Board comprised of these top medical and scientific experts from the medical marijuana field played an integral part in assisting Inergetics to create these best in class CBD products for their CBD initiative program, that will lead with a holistic, natural, opiate-free, pain relief supplement.
Dr. Michelle Sexton , who has helped write the monograph on CBD, and who is a highly-respected expert in the medicinal applications of cannabis, naturopathic medicine and the phytochemistry of plant medicine, with more than 15 years of experience in natural, herbal and holistic medicine. She currently serves as the Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle. For the past several years, she owned and operated Phytalytics LLC, doing business as PhytaLab, a phytochemical analysis company dedicated to developing and perfecting analytical platforms for the quality control of medical and adult use cannabis and related products in Washington state.
Dr. Yu Shao with extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.
Dr. Joseph McSherry , a Neurologist who has extensive knowledge of research involving the medical benefits of cannabis and its cannabinoids for pain management, medicinal and therapeutic use. He is a widely recognized academic expert on medical cannabis/cannabinoids and its many health benefits, and is also involved in several community service initiatives including his service on the State of Vermont's Marijuana Oversight Committee. Dr. McSherry is the author of numerous academic and public presentations on the medical use of cannabis/cannabinoids in general and as it relates to cancer and other specific medical conditions. He received theOutstanding Physician Advocate Award from the Washington, D.C.-based Marijuana Policy Project in 2010.
Dr. Mark Wallace who is an acclaimed anesthesiologist specializing in pain management, with deep experience researching innovative pain treatments and performing in-depth clinical trials on all types of pain. He is board certified in both anesthesiology and pain medicine in the State of California, and is on faculty at the University of California San Diego Health System and the Veterans Affairs San Diego Healthcare System. At UC San Diego, Dr. Wallace serves as the chair of the Division of Pain Medicine and is a Professor of Clinical Anesthesiology. He is also the Director, Division of Clinical Research, UCSD Clinical and Translational Research Institute. He is actively involved in all aspects of clinical care, graduate medical education/training and research. Dr. Wallace's research on pain medicine has been widely published in an extensive array of peer-reviewed medical journals and books. He is also the recipient of numerous grants, including grants from Pfizer, Medtronic and Abbott Laboratories.
Dr. Justin Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis. Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.
http://finance.yahoo.com/news/inergetics-scie...00600.html
http://finance.yahoo.com/news/inergetics-disc...00668.html
The differences that really standout between all these CBD companies flooding the market is quickly distinguished by who is supporting and endorsing them. Inergetics has the BEST of the BEST, who actually have a long background working and studying within the medical and scientific marijuana industry for many years. NRTI didn't just go out and pay someone to use their name to promote their company, they brought these experts in to also assist in making their CBD products, backed up with their research and clinical evidence. Inergetics has not only taken the right approach, but they have taken the approach physicians and clinicians will trust. This will make all the difference when this is launched throughout the US. The FDA is already taking steps to crack down on the masses of hustlers and unreliable companies in this space. Inergetics approach will be setting the new standard that the FDA will appreciate and look to adopt, to make the medical mj industry much safer for the public. In the end, only a few will be around, but some like NRTI, will not only survive, but will also lead the category! Cheers!
Inergetics SUPPORT & ENDORSEMENTS:
They brought in the most notable authorities in the medical marijuana industry to help create and endorse their one of a kind CBD products that they have also provided the scientific research and medical evidence to support its efficacy and safety. This impressive Scientific/Medical Advisory Board comprised of these top medical and scientific experts from the medical marijuana field played an integral part in assisting Inergetics to create these best in class CBD products for their CBD initiative program, that will lead with a holistic, natural, opiate-free, pain relief supplement.
Dr. Michelle Sexton , who has helped write the monograph on CBD, and who is a highly-respected expert in the medicinal applications of cannabis, naturopathic medicine and the phytochemistry of plant medicine, with more than 15 years of experience in natural, herbal and holistic medicine. She currently serves as the Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle. For the past several years, she owned and operated Phytalytics LLC, doing business as PhytaLab, a phytochemical analysis company dedicated to developing and perfecting analytical platforms for the quality control of medical and adult use cannabis and related products in Washington state.
Dr. Yu Shao with extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.
Dr. Joseph McSherry , a Neurologist who has extensive knowledge of research involving the medical benefits of cannabis and its cannabinoids for pain management, medicinal and therapeutic use. He is a widely recognized academic expert on medical cannabis/cannabinoids and its many health benefits, and is also involved in several community service initiatives including his service on the State of Vermont's Marijuana Oversight Committee. Dr. McSherry is the author of numerous academic and public presentations on the medical use of cannabis/cannabinoids in general and as it relates to cancer and other specific medical conditions. He received theOutstanding Physician Advocate Award from the Washington, D.C.-based Marijuana Policy Project in 2010.
Dr. Mark Wallace who is an acclaimed anesthesiologist specializing in pain management, with deep experience researching innovative pain treatments and performing in-depth clinical trials on all types of pain. He is board certified in both anesthesiology and pain medicine in the State of California, and is on faculty at the University of California San Diego Health System and the Veterans Affairs San Diego Healthcare System. At UC San Diego, Dr. Wallace serves as the chair of the Division of Pain Medicine and is a Professor of Clinical Anesthesiology. He is also the Director, Division of Clinical Research, UCSD Clinical and Translational Research Institute. He is actively involved in all aspects of clinical care, graduate medical education/training and research. Dr. Wallace's research on pain medicine has been widely published in an extensive array of peer-reviewed medical journals and books. He is also the recipient of numerous grants, including grants from Pfizer, Medtronic and Abbott Laboratories.
Dr. Justin Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis. Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.
http://finance.yahoo.com/news/inergetics-scie...00600.html
http://finance.yahoo.com/news/inergetics-disc...00668.html
(0)
(0)Inergetics Inc. (NRTI) Stock Research Links
Scroll down for more posts ▼